{"version":"1.0","type":"link","title":"Addition of Ianalumab (VAY736) to Ibrutinib in Patients with Chronic Lymphocytic Leukemia on Ibrutinib Therapy: Results from a Phase Ib Study.","author_name":"Rogers KA 외","author_url":"https://prs-insight.online/author/Rogers%20KA","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/164653","thumbnail_width":1200,"thumbnail_height":630}